FDA Committee Votes to Combine Bladder Pain, Interstitial Cystitis Patients in Trials

Drug Industry Daily
A A
An FDA advisory committee voted unanimously in favor of combining patients with bladder pain syndrome and interstitial cystitis in clinical trials citing the minimal differences in symptoms between the two populations.

To View This Article:

Login

Subscribe To Drug Industry Daily